Reuters -- Sanofi-Aventis could buy a 19.9 percent stake in Danish biotech Zealand Pharma for up to 100 million euros ($143 million), a paper said on Wednesday, as the drugmaker aims to make diabetes one of its key growth areas.
Reuters -- Sanofi-Aventis could buy a 19.9 percent stake in Danish biotech Zealand Pharma for up to 100 million euros ($143 million), a paper said on Wednesday, as the drugmaker aims to make diabetes one of its key growth areas.
